Study yields positive results for Boston Scientific's S-ICD system

04/2/2014 | (Boston)

A clinical study found that patients showed 100% and 99.7% treatment rates for spontaneous ventricular tachyarrhythmias and acute ventricular tachyarrhythmias, respectively, 12 months after receiving Boston Scientific's subcutaneous implantable cardioverter defibrillator, or S-ICD system. The findings were based on real-world data from more than 450 patients with abnormal heart rhythms.

View Full Article in: (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA